News and Events

Keep up-to-date on recent events, webinars and releases from ArcherDX.



Mar
4
2016

New Archer options revealed at USCAP 2016 Annual Meeting

Join us for the USCAP 2016 Annual Meeting in Seattle, WA from March 12-18. By combining revolutionary AMP™ chemistry with an easy workflow and intuitive software, Archer is unleashing the power of translational NGS to enable mutation detection.


Dec
2
2015

What's new in Archer Analysis 4.0?

See what's new in Archer Analysis 4.0. This update introduces many new features and enhancements, such as fusion visualization, RNA abundance, DNA variant filtering, user management and cloud options.


Oct
20
2015

Association of Molecular Pathology Annual Meeting 2015

Join us for the annual Association of Molecular Pathology Meeting in Austin, TX. By combining revolutionary Anchored Multiplex PCR chemistry with an easy-to-use workflow and intuitive software, Archer is unleashing the power of translational NGS to enable accurate and scalable mutation detection.


Oct
12
2015

ArcherDX Launches NGS Solution for Comprehensive Lung and Thyroid Tumor Profiling

The Archer™ Comprehensive Thyroid and Lung (CTL) Assay combines two complementary targeted NGS panels to detect gene fusions, point mutations, RNA abundance and copy number variations (CNVs) from FFPE and FNA lung and thyroid cancer samples.


Sep
29
2015

ArcherDX and BioChain to Provide NGS-characterized FFPE Tumor Samples

BioChain will supply ArcherDX with multiple types of tumor FFPE samples, including NSCLC samples, which will be comprehensively screened for oncogenic fusions, copy number variations (CNVs), single nucleotide variants (SNVs) and insertions/deletions (indels) using the Archer VariantPlex™ and FusionPlex™ Solid Tumor assays.


Sep
18
2015

Clinically actionable gene fusions, CNVs and SNVs detected by NGS-based comprehensive tumor profiling

Dr. A. John Iafrate, MD PhD discusses the practical challenges of clinical genotyping and how next-generation sequencing (NGS) and Anchored Multiplex PCR (AMP) technologies address those challenges in the clinic.


Aug
28
2015

Evolution of NGS-based detection of fusions, SNVs and CNVs using Anchored Multiplex PCR

Brian Kudlow, PhD, discusses the challenges of cancer genomics and how Archer technology addresses those challenges in the laboratory. Dr. Kudlow also discuss what Archer technology is moving towards in the future.


Jul
16
2015

Archer Analysis Software Webinar by Thon deBoer

New features discussed include the ability to probe DNA/RNA mutations and enumerate copy number variations, graphical metrics output, and better progress indications


Jun
16
2015

Dr. Kudlow speaks at Festival of Genomics, 2015

Seminar: Comprehensive tumor profiling: a targeted approach using purpose-built technology


May
22
2015

Beyond Fusions - Webinar by Josh Stahl

Josh Stahl, Vice-President of R&D and Scientific Operations at ArcherDX, describes the benefits of AMP chemistry and how it is best suited for DNA-based mutation detection. He will also discuss how Archer VariantPlex assays detect CNVs from DNA, and how combining FusionPlex and VariantPlex assays maximizes mutation detection from a single FFPE sample.


May
20
2015

Archer Analysis updated to version 3.2

Archer Analysis has been updated to version 3.2 to include support for CNV detection via Archer VariantPlex DNA panels and printable analysis reports.


May
20
2015

Meet the next-gen variant detection experts at ASCO 2015

To address the existing bottlenecks of using NGS in translational research, we’ve created a line of innovative products that are purpose-built for clinical oncology research. Learn how Archer™ NGS assays are revolutionizing RNA/DNA analysis.


Mar
10
2015

Identifying translocations in solid tumors: Webinar by Brady Culver, PhD

Brady Culver, PhD, Senior R&D Manager and Lead Scientist at ArcherDX, describes the challenges of gene fusions discovery in solid tumors and his process for developing and characterizing a comprehensive NGS panel to assess translocations in these tumor types.


Feb
16
2015

Archer assays are purpose-built for revolutionary mutation calling - Learn more at AGBT, 2015

To address the existing bottlenecks of using NGS in translational research, we’ve created a line of innovative products that are purpose-built for clinical oncology research. Learn how Archer™ NGS assays are revolutionizing RNA/DNA analysis.


Feb
2
2015

Change is not coming. Change is here. See ArcherDX at TriCon 2015

Join us at Molecular Medicine Tri-Conference 2015 to learn about how Archer™ FusionPlex™ Assays are bridging the gap between NGS and scalable, accurate and comprehensive gene fusion detection.


Jan
12
2015

ArcherDX Launches from QIAGEN Acquisition of Enzymatics

ArcherDX enters a strategic partnership with QIAGEN for distribution of targeted next-generation sequencing assays and Jason Myers, Ph.D., becomes Chief Executive Officer of ArcherDX


Dec
10
2014

The Value of Richer NGS Data Sets Using Anchored Multiplex PCR – Webinar by Brian Kudlow, PhD

In this webinar, Dr. Kudlow discussed catalog and custom Archer™ products built upon the AMP™ technology and reviewed the scope and power of the data generated with this technology.


Oct
7
2014

Archer Analysis Pipeline update, version 3.0

The Archer Analysis Pipeline has been updated from version 2.1 to 3.0 to bring greater functionality, faster analysis and more comprehensive reporting.


Jun
13
2014

Archer Analysis Pipeline updates, Version 2.1

Archer Analysis Pipeline version 2.1 updates include improved detection of complex gene fusions, targeted mutation reporting, improved handling of very deeply sequenced samples, and several bug fixes.

Subscribe to stay in the loop







How to contact us

Address

2477 55th Street, Suite 202

Boulder, CO 80301

Phone

Phone: (877) 771 1093

Phone: (303) 357 9001

All content © 2017 ArcherDX, Inc.

For Research Use Only. Not for use in diagnostic procedures. For Research Use Only. Not for use in diagnostic procedures.